Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Protalex Significantly Strengthens Global Intellectual Property Portfolio for Proprietary Immunomodulatory Therapeutic

$
0
0
Granted Six Key International Patents Protecting and Expanding Use for PRTX100 Protalex Inc. OTCQBPRTX a clinicalstage biopharmaceutical company announces that the Company has been granted several key patents for PRTX100 th...

Viewing all articles
Browse latest Browse all 2985

Trending Articles